Abiopharma

Ramachandran Ramesh 🟢 acquired 518.2K shares (1 derivative) of Ocugen, Inc. (OCGN) at $1.38 Transaction Date: Jan 02, 2026 | Filing ID: 000019

Jacobson Allan Steven 🟢 acquired 7.5K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 Transaction Date: Jan 02, 2026 | Filing ID: 000002

SCHMERTZLER MICHAEL 🟢 acquired 14.9K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Gravier Pierre 🟢 acquired 70.0K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 ($3.8M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Klein Matthew B. 🟢 acquired 220.5K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 ($12.1M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

STEELE GLENN JR MD PHD 🟡 adjusted position in 4.5K shares (2 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 ($1.9M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

Behner Peter 🟢 acquired 5.4K shares (1 derivative) of MiNK Therapeutics, Inc. (INKT) at $11.12 Transaction Date: Jan 02, 2026 | Filing ID: 004769

Baxter - Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Director Mauricio Maxine Lum 🟡 adjusted position in 1.8K shares (2 derivative) of NOVANTA INC (NOVT) Transaction Date: Jan 02, 2026 | Filing ID: 000019

📋 RAJU PRASAD (Officer) plans to sell 30K shares of CRISPR THERAPEUTICS AG (at $60.16 each, total $1.8M) Filed: Jan 06, 2026 | ID: 000216

Director Young Caroline 🟢 acquired 66 shares of CUMBERLAND PHARMACEUTICALS INC (CPIX) at $4.32 Transaction Date: Dec 01, 2025 | Filing ID: 000008

Director Jones James 🟢 acquired 270 shares of CUMBERLAND PHARMACEUTICALS INC (CPIX) at $4.32 Transaction Date: Dec 01, 2025 | Filing ID: 000006

Director KAZIMI A J 🟢 acquired 270 shares of CUMBERLAND PHARMACEUTICALS INC (CPIX) at $4.32 Transaction Date: Dec 01, 2025 | Filing ID: 000004

Director Krogulski Kenneth 🟢 acquired 1.9K shares of CUMBERLAND PHARMACEUTICALS INC (CPIX) at $4.32 Transaction Date: Dec 01, 2025 | Filing ID: 000002

Kalb Michael Wayne 🟡 adjusted position in 2.1K shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) Transaction Date: Jan 05, 2026 | Filing ID: 000022